These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 28485264

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
    Csiky B, Kovács T, Wágner L, Vass T, Nagy J.
    Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483
    [Abstract] [Full Text] [Related]

  • 25. Association between the rate of the morning surge in blood pressure and cardiovascular events and stroke.
    Luo Y, Wang YL, Wu YB, Xu Y, Head GA, Barry M, Liang YL.
    Chin Med J (Engl); 2013 Feb; 126(3):510-4. PubMed ID: 23422116
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM, Hopkins MT, Weston PJ, Fraser WD, Vora JP.
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [Abstract] [Full Text] [Related]

  • 28. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP, Nisse-Durgeat S, Mouret S, Asmar R, Mallion JM.
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quantitative study of circadian variations of ambulatory blood pressure in Chinese healthy, hypertensive, and diabetes subjects.
    Zhao ZY, Zhao ZY, Wang YQ, Yan ZH, Cui J, Li YY.
    Clin Exp Hypertens; 2005 Apr; 27(2-3):187-94. PubMed ID: 15835381
    [Abstract] [Full Text] [Related]

  • 32. Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects.
    Magen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C.
    J Hum Hypertens; 2005 Sep; 19(9):667-73. PubMed ID: 16034448
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of an olmesartan medoxomil-based treatment algorithm in patients with hypertension and type 2 diabetes: analysis of diurnal blood pressure control as assessed by 24-hour ambulatory blood pressure monitoring.
    Kereiakes DJ, Neutel J.
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):285-93. PubMed ID: 20801941
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G, van Montfrans GA, Jacobs MC, de Bruijn JH, Veerman DP, van Es PN, Mellein B, Guitard C, Thien T, de Leeuw PW.
    Blood Press Suppl; 1994 Nov; 2():23-30. PubMed ID: 8061842
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.